亏损扩大5倍后，均瑶健康高管再启减持

Core Viewpoint - Junyao Health (605388) is expected to report a net loss of between 144 million to 216 million yuan for 2025, significantly increasing from a net loss of 29 million yuan in the previous year, indicating a deterioration in financial performance [1] Financial Performance - The total revenue for Junyao Health for the quarter ending December 31, 2024, was 1.458 billion yuan, down from 1.634 billion yuan in the same quarter the previous year [2] - The gross profit for the same period was 441.9 million yuan, compared to 399.2 million yuan a year earlier [2] - The net profit attributable to shareholders was a loss of 29.12 million yuan, contrasting with a profit of 57.58 million yuan in the previous year [2] Business Challenges - The company attributes its projected losses to a shrinking market share in the dairy beverage sector, driven by weak consumer demand [3] - Increased sales and marketing expenses due to efforts to optimize revenue structure and expand into e-commerce and new retail channels have negatively impacted profitability [3] - The company plans to recognize asset impairment provisions for inventory, credit, and goodwill, which are expected to affect profits by 30 million to 50 million yuan, 50 million to 90 million yuan, and 15 million to 45 million yuan, respectively [3] Management Actions - A group of five executives at Junyao Health announced plans to reduce their shareholdings between February 6 and May 5, citing personal financial needs [4] - The largest planned reduction comes from executive Xiang Weibing, who intends to sell up to 69,000 shares, potentially cashing out around 500,000 yuan based on the current share price [4] - This is not the first instance of share reduction by executives, as eight executives have sold shares over the past two years, raising concerns about the company's long-term value [5][6]